---
title: "These Analysts Slash Their Forecasts On Equifax After Q2 Results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293498683.md"
description: "Equifax beat Q2 earnings and revenue estimates but issued lower Q3 forecasts, causing shares to fall 2.5%. Consequently, analysts from Needham, Barclays, and RBC Capital lowered their price targets while maintaining their respective buy or hold ratings on the stock."
datetime: "2026-07-22T16:07:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293498683.md)
  - [en](https://longbridge.com/en/news/293498683.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293498683.md)
generator: "portal-rs"
---

# These Analysts Slash Their Forecasts On Equifax After Q2 Results

**Equifax Inc.** (NYSE:EFX) on Tuesday posted upbeat second-quarter results and issued third-quarter forecasts that came in below Wall Street expectations.

Adjusted earnings were $2.25 per share, topping the analyst consensus estimate of $2.20. Revenue rose 11% year over year to $1.70 billion, ahead of the $1.696 billion consensus estimate. On a local currency basis, revenue increased 10%.

Equifax narrowed its full-year adjusted EPS guidance to $8.39 to $8.69 from a previous range of $8.34 to $8.74. The midpoint remains in line with the analyst consensus estimate of $8.60.

The company also tightened its full-year revenue outlook to $6.71 billion-$6.78 billion from $6.685 billion-$6.805 billion. The midpoint is broadly in line with the consensus estimate of $6.764 billion.

For the third quarter, Equifax forecast adjusted EPS of $2.15 to $2.25, below the analyst estimate of $2.26. It expects revenue of $1.68 billion to $1.71 billion, compared with the consensus estimate of $1.711 billion.

Equifax shares fell 2.5% to trade at $168.72 on Wednesday.

These analysts made changes to their price targets on Equifax following earnings announcement.

-   Needham analyst Kyle Peterson maintained the stock with a Buy and lowered the price target from $265 to $245.
-   Barclays analyst Manav Patnaik maintained the stock with an Equal-Weight rating and cut the price target from $215 to $200.
-   RBC Capital analyst Ashish Sabadra maintained the stock with an Outperform rating and lowered the price target from $222 to $194.

**Considering buying EFX stock? Here’s what analysts think:**

*Photo via Shutterstock*

### Related Stocks

- [EFX.US](https://longbridge.com/en/quote/EFX.US.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)
- [RY.US](https://longbridge.com/en/quote/RY.US.md)
- [SSTK.US](https://longbridge.com/en/quote/SSTK.US.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)

## Related News & Research

- [Equifax EVP, CFO & COO John W. Gamble Jr sells 4,500 shares worth $845,820](https://longbridge.com/en/news/298359904.md)
- [Jupiter Topco LLC Purchases New Position in Equifax, Inc. $EFX](https://longbridge.com/en/news/298005242.md)
- [Analysts’ Top NA Picks: VGP NV (VGPBF), FMC (FMC)](https://longbridge.com/en/news/298138766.md)
- [Equifax notifies availability of 8-K filing](https://longbridge.com/en/news/297785672.md)
- [Does Equifax's (EFX) Century-Long Dividend Streak Clarify Its Capital Allocation Priorities Today?](https://longbridge.com/en/news/296583084.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**